With approximately 40% of new APIs hindered by poor water solubility, pharmaceutical companies face significant bioavailability challenges affecting efficacy, side effect profiles, and market competitiveness. Clariant addresses these challenges with our comprehensive range of PEGs and PEG-derivatives that effectively enhance API solubility. Our specialized solubilizers improve bioavailability and therapeutic performance while accelerating time-to-market for pharmaceutical formulations.